995 results on '"Zembala, Marian"'
Search Results
52. Comparison of Outcomes of Direct Stenting Versus Stenting After Balloon Predilation in Patients With Acute Myocardial Infarction (DIRAMI)
53. Adjunctive therapy with low-molecular-weight heparin in patients with chronic heart failure secondary to dilated cardiomyopathy: One-year follow-up results of the randomized trial
54. Long-term results of 11,021 patients with chronic coronary syndrome and after coronarography (from the PRESAGE Registry)
55. Mechanical circulatory support restores eligibility for heart transplant in patients with significant pulmonary hypertension
56. Single Lung Transplantation With Concomitant Cardiac Surgery in a Patient With Cystic Fibrosis: A Case Report
57. Outcomes of primary coronary angioplasty and angioplasty after initial thrombolysis in the treatment of 374 consecutive patients with acute myocardial infarction
58. Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
59. Chapter 28 Renal support therapy
60. Transcatheter Versus Surgical Valve Replacement: A 24-months Propensity-matched Analysis of the SILCARD Registry.
61. Usefulness of Atorvastatin in Patients With Heart Failure Due to Inflammatory Dilated Cardiomyopathy and Elevated Cholesterol Levels
62. Ghrelin PYY 3-36 Serum Changes in Left Ventricular Hypertrophic, Insulin-Resistant, Hypertensive Obese Patients
63. IMPROVEMENT OR STABILIZATION OF RENAL FUNCTION AFTER LATE INTRODUCTION OF EVEROLIMUS IN HEART TRANSPLANT RECIPIENTS - 12 MONTH FOLLOW-UP: RO-157
64. FREQUENT OCCURRENCE OF DERMATOLOGIC COMPLICATION AFTER REPLACEMENT OF CALCINEURIN INHIBITOR WITH EVEROLIMUS LATE AFTER HEART TRANSPLANTATION: RO-156
65. Effectiveness of Lung Transplantation in Patients With Interstitial Lung Diseases
66. Single Lung Transplant vs Double Lung Transplant: A Single-Center Experience With Particular Consideration for Idiopathic Pulmonary Arterial Hypertension
67. Assessment of Quality of Life Among Patients After Lung Transplantation: A Single-Center Study
68. Bronchoscopic Interventions as a Management of Airway Complications After Lung Transplant Including Assessment of Risk Factors With Special Consideration for Pretransplant Pulmonary Hypertension
69. Extracorporeal Membrane Oxygenation as a Postoperative Left Ventricle Conditioning Tool After Lung Transplantation in Patients With Primary Pulmonary Artery Hypertension: First Polish Experience
70. Impact of Cold Ischemia Time on Frequency of Airway Complications Among Lung Transplant Recipients
71. Outcome of Lung Transplantation as a Treatment of Patients With Chronic Obstructive Pulmonary Disease: A Single-Center Study
72. Secondary Pulmonary Hypertension Among Patients Qualified for Lung Transplantation: Single-Center Study
73. Suboptimal Donors Do Not Mean Worse Results: A Single-Center Study of Extending Donor Criteria for Lung Transplant
74. Interleukin 6 and Interleukin 10 in Patients Before and After Lung Transplantation
75. Donor-related Risk Factors Associated With Increased Mortality After Lung Transplant
76. The Impact of Airway Complications on Survival Among Lung Transplant Recipients
77. Extracorporeal Membrane Oxygenation as a Bridge to Lung Transplantation: First Polish Experience
78. Model for End-Stage Liver Disease (MELD) Score Among Patients Qualified For Lung Transplantation With End-Stage Lung Diseases With Particular Consideration of Median Pulmonary Artery Pressure
79. Microbiological Status as a Factor of Airway Complications After Lung Transplantation
80. An 18-year follow-up after the first successful heart-lung transplant in Poland. Authors’ tribute to the pioneers of heart and lung transplantation
81. Long-term echocardiographic evaluation of asymptomatic patients undergoing minimally invasive valve repair for severe primary mitral regurgitation
82. Short and long-term outcomes of continuous-flow left ventricular assist device therapy in 79 patients with end-stage heart failure
83. Long-Term Survival Following Surgical Ablation for Atrial Fibrillation Concomitant to Isolated and Combined Coronary Artery Bypass Surgery—Analysis from the Polish National Registry of Cardiac Surgery Procedures (KROK)
84. Everolimus-Eluting Second-Generation Stents for Treatment of De Novo Lesions in Patients with Cardiac Allograft Vasculopathy
85. Successful Treatment of Aortic Sutureless Valve Degeneration Using the Self-expandable Acurate Neo Percutaneous Prosthesis
86. Hemodynamic Outcome at 5y of the Perceval Sutureless Valve: Results from an International Prospective Trial
87. The Long Term Outcome of Treatment in Patients with Ischemic Mitral Regurgitation Subjected to Valve Repair or Replacement in the Polish Population Based on Data from the National Registry of Cardiac Surgery Procedures
88. Vascular access site complications after transfemoral transcatheter aortic valve implantation in the POL-TAVI Registry: surgical versus percutaneous approach
89. A modified heterotopic heart transplantation in the rat – as an important model in experimental regeneration and replacement of the failing organ
90. Can mild anaemia increase the risk of complications in patients over 65 years of age compared to younger patients undergoing cardiac surgery?
91. Retrospective cohort study of patients qualified for lung transplantation due to idiopathic pulmonary fibrosis – single-centre experience
92. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
93. Heart Rate Turbulence for Prediction of Heart Transplantation and Mortality in Chronic Heart Failure
94. Surgical ablation for atrial fibrillation during isolated coronary artery bypass surgery
95. Lipomatous Hypertrophy of the Interatrial Septum: A Rare Cause of Right Ventricular Impairment
96. ADVANCED GLYCATION END-PRODUCTS IN PATHOLOGY OF THE TRANSPLANTED HEART: O-100
97. Triple-Site Versus Standard Cardiac Resynchronization Therapy Study (TRUST CRT): Clinical Rationale, Design, and Implementation
98. A differential release of matrix metalloproteinases 9 and 2 during coronary artery bypass grafting and off-pump coronary artery bypass surgery
99. Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology
100. Different Types of Renal Dysfunction in Patients with Acute Myocardial Infarction Treated with Percutaneous Coronary InterventionDifferent Types of Renal Dysfunction in Patients with Acute Myocardial Infarction Treated with Percutaneous Coronary Intervention
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.